RXO (NYSE:RXO) Cut to Neutral at Citigroup

Citigroup lowered shares of RXO (NYSE:RXOFree Report) from a buy rating to a neutral rating in a report published on Tuesday, Marketbeat reports. They currently have $33.00 price objective on the stock.

Other research analysts also recently issued research reports about the stock. UBS Group upped their target price on shares of RXO from $22.00 to $31.00 and gave the stock a “neutral” rating in a report on Thursday, August 8th. Jefferies Financial Group cut their target price on RXO from $33.00 to $31.00 and set a “buy” rating for the company in a research report on Tuesday, August 13th. JPMorgan Chase & Co. boosted their price target on RXO from $25.00 to $26.00 and gave the stock an “underweight” rating in a report on Thursday, August 8th. Oppenheimer reaffirmed an “outperform” rating and set a $31.00 price objective on shares of RXO in a report on Tuesday, September 17th. Finally, Wells Fargo & Company reissued an “equal weight” rating and issued a $31.00 target price on shares of RXO in a report on Monday, November 11th. Two research analysts have rated the stock with a sell rating, eleven have issued a hold rating and three have given a buy rating to the company’s stock. According to MarketBeat.com, RXO currently has an average rating of “Hold” and a consensus price target of $26.29.

Check Out Our Latest Report on RXO

RXO Stock Down 0.9 %

RXO stock opened at $27.25 on Tuesday. The business’s 50-day moving average price is $27.85 and its 200-day moving average price is $26.04. The stock has a market cap of $4.38 billion, a P/E ratio of -13.76, a PEG ratio of 15.00 and a beta of 1.33. The company has a quick ratio of 1.33, a current ratio of 1.33 and a debt-to-equity ratio of 0.21. RXO has a twelve month low of $18.75 and a twelve month high of $32.82.

RXO (NYSE:RXOGet Free Report) last released its earnings results on Thursday, November 7th. The company reported $0.05 EPS for the quarter, topping analysts’ consensus estimates of $0.04 by $0.01. The company had revenue of $1.04 billion for the quarter, compared to analysts’ expectations of $956.19 million. RXO had a negative net margin of 6.81% and a positive return on equity of 1.64%. The firm’s revenue was up 6.6% compared to the same quarter last year. During the same quarter last year, the business earned $0.05 EPS. On average, equities research analysts forecast that RXO will post 0.12 EPS for the current year.

Institutional Trading of RXO

Several hedge funds and other institutional investors have recently bought and sold shares of RXO. Nomura Asset Management Co. Ltd. increased its position in RXO by 68.7% during the third quarter. Nomura Asset Management Co. Ltd. now owns 1,400 shares of the company’s stock valued at $39,000 after acquiring an additional 570 shares during the last quarter. GAMMA Investing LLC raised its position in RXO by 40.0% in the 3rd quarter. GAMMA Investing LLC now owns 1,784 shares of the company’s stock worth $50,000 after purchasing an additional 510 shares during the period. Motco raised its position in RXO by 5,450.0% in the 1st quarter. Motco now owns 2,442 shares of the company’s stock worth $53,000 after purchasing an additional 2,398 shares during the period. Allspring Global Investments Holdings LLC lifted its stake in RXO by 2,235.3% in the first quarter. Allspring Global Investments Holdings LLC now owns 3,643 shares of the company’s stock worth $80,000 after purchasing an additional 3,487 shares during the last quarter. Finally, Canada Pension Plan Investment Board bought a new position in shares of RXO during the second quarter valued at approximately $112,000. Hedge funds and other institutional investors own 92.73% of the company’s stock.

About RXO

(Get Free Report)

RXO, Inc provides full truckload freight transportation brokering services. It also offers brokered services for managed transportation, last mile, and freight forwarding. The company was incorporated in 2022 and is based in Charlotte, North Carolina.

Recommended Stories

Analyst Recommendations for RXO (NYSE:RXO)

Receive News & Ratings for RXO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RXO and related companies with MarketBeat.com's FREE daily email newsletter.